CYM2503
CAS No. 1308833-36-4
CYM2503( —— )
Catalog No. M23466 CAS No. 1308833-36-4
CYM2503 is a positive allosteric modulator (PAM) of the GAL2 receptor that potentiates galanin-induced IP1 production in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 69 | In Stock |
|
| 10MG | 112 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 50MG | 355 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | 682 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCYM2503
-
NoteResearch use only, not for human use.
-
Brief DescriptionCYM2503 is a positive allosteric modulator (PAM) of the GAL2 receptor that potentiates galanin-induced IP1 production in vitro.
-
DescriptionCYM2503 is a positive allosteric modulator (PAM) of the GAL2 receptor that potentiates galanin-induced IP1 production in vitro. It has no affinity for the orthosteric galanin binding site of the receptor (as measured by its inability to displace iodinated galanin, or to induce IP1 accumulation on its own).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeuropeptide Y Receptor
-
RecptorGAL2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1308833-36-4
-
Formula Weight777.96
-
Molecular FormulaC45H55N5O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(N[C@H](C(N[C@@H](CCCCNC(OC(C)(C)C)=O)C(NC1=CC=C(C(C)=C2)C(NC2=O)=C1)=O)=O)CC3CCCCC3)OCC4C5=CC=CC=C5C6=CC=CC=C46
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lu X , Roberts R , Xia R , et al. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models[J]. Proc Natl Acad Sci U S A, 2010, 107(34):15229-15234.
molnova catalog
related products
-
Velneperit
Velneperit is potent and selective neuropeptide Y (NPY) Y5 receptor under evaluating for treatment of obesity.
-
M617
Selective galanin GAL1 receptor agonist (Ki values are 0.23 and 5.71 nM for GAL1 and GAL2 receptors respectively). Enhances food consumption in rats following i.c.v. administration and reduces CAP-induced inflammatory pain.
-
Selvigaltin
Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.
Cart
sales@molnova.com